These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33278493)

  • 1. 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment.
    Ghanizadeh Tabriz A; Nandi U; Hurt AP; Hui HW; Karki S; Gong Y; Kumar S; Douroumis D
    Int J Pharm; 2021 Jan; 593():120147. PubMed ID: 33278493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Xu P; Chung S; Bandari S; Repka MA
    Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion.
    Oh HS; Park JB
    Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring tablet design options for tailoring drug release and dose via fused deposition modeling (FDM) 3D printing.
    Gorkem Buyukgoz G; Soffer D; Defendre J; Pizzano GM; Davé RN
    Int J Pharm; 2020 Dec; 591():119987. PubMed ID: 33069894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
    Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
    Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
    Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
    Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive overview of extended release oral dosage forms manufactured through hot melt extrusion and its combination with 3D printing.
    Nashed N; Lam M; Nokhodchi A
    Int J Pharm; 2021 Mar; 596():120237. PubMed ID: 33484928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion.
    Bhatt U; Malakar TK; Murty US; Banerjee S
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets.
    Larsen BS; Kissi E; Nogueira LP; Genina N; Tho I
    Eur J Pharm Sci; 2024 Jan; 192():106619. PubMed ID: 37866675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the degradation and in-situ amorphization of the enantiomeric drug escitalopram oxalate during Fused Deposition Modeling (FDM) 3D printing.
    Hoffmann L; Breitkreutz J; Quodbach J
    Eur J Pharm Sci; 2023 Jun; 185():106423. PubMed ID: 36918059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.
    Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S
    J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
    Chung S; Zhang P; Repka MA
    Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
    Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
    Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.